Federation for Innovative Drug Research Netherlands (FIGON)
FIGON is the integrative platform for innovative drug research in the Netherlands. The Dutch Medicines Days is the conference where partners from Institutes, Industry, and Government can present their findings, share new scientific content and strengthen their network.
We are proud to have participated with three sessions to the 2021 FIGON program.
15 September 2020
Topic: Affordable & Sustainable Drug Development
Due to the Coronavirus (COVID-19), a physical meeting was not possible. The health and safety of our members, speakers and attendees is our number one priority. Even in the midst of COVID-19, the work cannot stop – we must continue to meet, engage, learn and advance. Therefore, DMD edition will be organised virtually.
Anke-Hilse Maitland – van der Zee, chairman of the FIGON officially started the virtual DMD on September 15 . She highlighted the background of, and the challenges for, the FIGON, followed by a keynote lecture by Clémence Ross-van Dorp, ambassador for the Life, Science & Health sector. Afterwards, the Ariëns lecture was provided by Prof. Rowland.
The theme was affordable and sustainable drug development. Many new developments are influencing innovation in our field. Big data and artificial intelligence (AI) open new doors in all stages from drug discovery to clinical practice. Other developments, such as options to intervene at the RNA level, quicker ways to screen promising small molecules, and the pressing need for new antibiotics all speed up innovation. These are exciting times in pharmaceutical sciences. Bringing together all bright minds in this field in the Netherlands – established as well as young researchers – the DMD will create momentum for innovation.
– Prof. Roos Masereeuw, professor of Experimental Pharmacology at Utrecht University
Title: Bioengineered kidney tubules for regenerative pharmacology
– Dr. Wileke Daamen, Principal investigator, Reconstructive & Regenerative Medicine of Radboud university medical center
Title: Biomaterials for soft tissue regeneration
– Xinhui Wu, PhD Researcher, University of Groningen
Title: Regenerative Pharmacology for COPD
– Dr. Anca Pasca, Assistant Professor of Pediatrics, Neonatology at Stanford University
Title: Human Cellular Models for Hypoxic Brain Injury of Prematurity
– Prof. Amalia Dolga, Associate Professor at University of Groningen
Title: Human stem cell models for targeting mitochondria and inflammation in neurodegeneration
– Tessa de Vries, PhD Researcher, Erasmus University Medical Center
Title: Validation of vessel-on-chip model using cells from HTNB patients
Associated dutch press media: Medicines
Medicines is an independent journal on drug research in the broadest sense of the word. Medicines provides news, backgrounds, interviews and opinions about the development of new medicines. This journal covers a variety of topics ranging from fundamental research to clinical studies, from policy to the shop floor, from opinions to hard facts, and from academy to start-ups and large pharmaceutical companies.
Medicines is published by Vakbladen.com for the Federation for Innovative Drug Research Netherlands (FIGON).
Our session “Regenerative pharmacology” was featured on the Medicine cover page.
More information can be found on the website.